In these studies, the investigators could not observe a beneficial effect of DPP4 inhibition on the combined risk of cardiovascular death, myocardial infarction and stroke in diabetic patients22,23,25–27, nor could in a reproducible way a beneficial renal effect be shown22. The gene discussed is DPP4; the disease is myocardial infarction.